1. Home
  2. NVAX vs USA Comparison

NVAX vs USA Comparison

Compare NVAX & USA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$7.45

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

USA

Liberty All-Star Equity Fund

HOLD

Current Price

$6.31

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVAX
USA
Founded
1987
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.9B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
NVAX
USA
Price
$7.45
$6.31
Analyst Decision
Hold
Analyst Count
8
0
Target Price
$9.75
N/A
AVG Volume (30 Days)
3.4M
880.5K
Earning Date
02-26-2026
01-01-0001
Dividend Yield
N/A
9.66%
EPS Growth
N/A
N/A
EPS
2.07
N/A
Revenue
$1,064,651,000.00
N/A
Revenue This Year
$58.91
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.68
N/A
Revenue Growth
20.27
N/A
52 Week Low
$5.01
$5.62
52 Week High
$11.55
$7.09

Technical Indicators

Market Signals
Indicator
NVAX
USA
Relative Strength Index (RSI) 62.21 56.36
Support Level $6.60 $6.22
Resistance Level $7.76 $6.40
Average True Range (ATR) 0.23 0.07
MACD 0.12 0.01
Stochastic Oscillator 75.43 67.31

Price Performance

Historical Comparison
NVAX
USA

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About USA Liberty All-Star Equity Fund

Liberty All Star Equity Fund is a multi-managed fund. Its objective is to provide a high level of current income and long-term capital appreciation through investing principally in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication, and other services.

Share on Social Networks: